Strategic Global Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-73,431
| Closed | -$6.27M | – | 169 |
|
|
2019
Q2 | $6.27M | Buy |
73,431
+1,123
| +2% | +$95.9K | 1.34% | 14 |
|
|
2019
Q1 | $7.82M | Buy |
72,308
+308
| +0.4% | +$33.3K | 1.64% | 11 |
|
|
2018
Q4 | $6.09M | Sell |
72,000
-1,898
| -3% | -$161K | 2.18% | 10 |
|
|
2018
Q3 | $7.26M | Sell |
73,898
-180
| -0.2% | -$17.7K | 2.2% | 10 |
|
|
2018
Q2 | $7.31M | Hold |
74,078
| – | – | 1.86% | 14 |
|
|
2018
Q1 | $7.31M | Hold |
74,078
| – | – | 2.5% | 7 |
|
|
2017
Q4 | $7.76M | Sell |
74,078
-741
| -1% | -$77.6K | 2.52% | 7 |
|
|
2017
Q3 | $8.43M | Sell |
74,819
-780
| -1% | -$87.9K | 3.23% | 5 |
|
|
2017
Q2 | $8.47M | Sell |
75,599
-5,142
| -6% | -$576K | 3.12% | 5 |
|
|
2017
Q1 | $9.42M | Sell |
80,741
-691
| -0.8% | -$80.6K | 3.4% | 5 |
|
|
2016
Q4 | $8.57M | Buy |
81,432
+1,201
| +1% | +$126K | 3.18% | 5 |
|
|
2016
Q3 | $11.3M | Hold |
80,231
| – | – | 4.23% | 4 |
|
|
2016
Q2 | $11.7M | Buy |
80,231
+12,708
| +19% | +$1.85M | 4.42% | 4 |
|
|
2016
Q1 | $9.67M | Buy |
67,523
+19,369
| +40% | +$2.77M | 4.11% | 4 |
|
|
2015
Q4 | $7.44M | Buy |
48,154
+22,383
| +87% | +$3.46M | 3.17% | 4 |
|
|
2015
Q3 | $3.68M | Sell |
25,771
-21,177
| -45% | -$3.03M | 1.76% | 11 |
|
|
2015
Q2 | $6.75M | Buy |
46,948
+4,048
| +9% | +$582K | 3.94% | 3 |
|
|
2015
Q1 | $6.05M | Buy |
42,900
+454
| +1% | +$64K | 4.47% | 2 |
|
|
2014
Q4 | $6.29M | Buy |
+42,446
| New | +$6.29M | 5.6% | 2 |
|